Ramalingam named deputy director of Winship Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

SURESH RAMALINGAM was named deputy director of the Winship Cancer Institute of Emory University. He will also serve as assistant dean for cancer research at the Emory School of Medicine. Ramalingam will lead the integration of the research, clinical, and educational components within Winship. This position was previously held by Fadlo Khuri, who assumed the...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Top FDA officials said the agency is in the process of removing the black box safety warnings from all forms of menopausal hormone therapy, including creams, pills, and other treatments prescribed to ease the symptoms of menopause and perimenopause.
With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login